MedTrace Logo

Study to Assess Participant Satisfaction After Jawline and Neck Treatment

NCT07794891 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-31

No results posted yet for this study

Summary

The goal of this study is to evaluate overall participant satisfaction with the jawline and neck.

Participants will receive select Juvéderm products and onabotulinumtoxinA in the jaw area and neck per eligibility criteria.

The study will measure changes in psychological function, satisfaction with lower face and jawline and skin appearance. Participants will attend visits during the study at a clinical site. The effects of the treatment will be checked by medical assessments, vital signs, physical examinations, checking for side effects, and completing questionnaires.

Conditions

  • Jawline and Neck Appearance

Interventions

DRUG

OnabotulinumtoxinA

Injection

DEVICE

SKINVIVE

Injection

DEVICE

VOLUX

Injection

DEVICE

VOLUMA

Injection

Sponsors & Collaborators

Principal Investigators

  • ABBVIE INC. · AbbVie

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-04
Primary Completion
2027-06-30
Completion
2027-06-30
FDA Drug
Yes
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07794891 on ClinicalTrials.gov